登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002047 证券简称：*ST宝鹰 公告编号：2026-001 深圳市宝鹰建设控股集团股份有限公司 第八届董事会第三十七次会议决议公告 本议案在提交董事会审议前，已经公司第八届董事会第十二次独立董事专门会议以3票同意、0票反对、 0票弃权的表决结果审议通过，同时已经公司第八届董事会审计委员会第二十二次会议以3票同意、0票 反对、0票弃权的表决结果审议通过。 本次交易构成关联交易。本次关联交易尚需提交公司2026年第一次临时股东会审议。为提高决策效率， 董事会提请股东会授权公司管理层在上述借款额度和有效期内办理与本次借款相关的具体事宜，并签署 相关合同文件。 具体内容详见公司同日于指定信息披露媒体《证券时报》《证券日报》《上海证券报》《中国证券报》 及巨潮资讯网（http://www.cninfo.com.cn）披露的《关于向海南世通纽投资有限公司借款暨关联交易及 向子公司提供借款的公告》（公告编号：2026-002）。 2、会议以8票同意，0票反对，0票弃权，审议通过了《关于向全资子公司提供借款的议案》； 因经营发展需要，公司拟向全资子公司澜兴科技提 ...

平顶山天安煤业股份有限公司（以下简称"公司"）第十届董事会第二次会议于2026年1月5日以书面、短 信或电子邮件的方式发出通知，于2026年1月8日采用通讯表决的方式召开，董事长焦振营先生主持。本 次会议应表决董事15人，实际表决董事15人。会议召开及程序符合《公司法》等法律、法规及《公司章 程》的有关规定。经与会董事审议，本次董事会会议通过如下事项： 证券代码：601666 证券简称：平煤股份 编号：2026-006 平顶山天安煤业股份有限公司 第十届董事会第二次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担个别及连带责任。 一、关于2025年日常关联交易执行情况及2026年发生额预计情况的议案 会议以11票同意，0票反对，0票弃权审议通过该议案。（内容详见2026-007号公告） 董事会审议该关联交易议案时，关联董事李庆明先生、焦振营先生、吴昕先生、陈金伟先生已回避表 决，也未代理非关联董事行使表决权。本议案已经公司第十届董事会独立董事专门会议2026年第一次会 议事前认可。 证券代码：601666 证券简称：平煤股份 ...

Core Viewpoint - Beijing Tongyi New Material Technology Co., Ltd. plans to sign an electricity retail transaction contract with its affiliate, Guotou Gansu Electricity Sales Co., Ltd., which constitutes a related party transaction within its daily operations [2][4]. Group 1: Overview of Related Party Transaction - The transaction involves the purchase of all commercial electricity by the company's Xintai branch from Guotou Gansu, which is controlled by the company's actual controller, the National Development Investment Corporation [4][5]. - This transaction does not constitute a major asset restructuring as defined by relevant regulations, and it has not exceeded 30 million yuan in related party transactions over the past 12 months [5][6]. Group 2: Related Party Information - Guotou Gansu Electricity Sales Co., Ltd. is a limited liability company with a registered capital of 21 million yuan, established on December 1, 2015 [6][7]. - The company reported total assets of 237.63 million yuan, net assets of 225.42 million yuan, and an operating income of 37.51 million yuan for the year 2024, with a net profit of -0.1471 million yuan [7]. Group 3: Pricing and Fairness of the Transaction - The pricing for the electricity will be based on the monthly retail market reference price, adjusted for operational costs and other fees, ensuring it aligns with market standards [9][10]. - The transaction pricing is deemed fair and reasonable, with no detriment to the interests of the company or its shareholders, particularly minority shareholders [10][21]. Group 4: Agreement Details and Compliance - The contract period for the electricity retail transaction is set from January 2026 to April 2026, with the Xintai branch agreeing to purchase all electricity within this period [11][12]. - The payment for electricity will be made directly to the power grid company, not to the related party, ensuring compliance with the established contractual obligations [20]. Group 5: Necessity and Impact of the Transaction - This related party transaction is essential for the company's daily operations and aims to reduce production costs, aligning with the company's overall interests [21]. - The transaction is structured to avoid any adverse effects on the company's ongoing operations or independence [21][22]. Group 6: Approval Process - The transaction was approved by the company's board of directors and independent directors, confirming its necessity and fairness, and it does not require shareholder meeting approval [22][23].

● 中石化股份持有本公司已发行股本约51.81%，为本公司的控股股东，中石化股份持有湖南石化 74.69%股权，湖南石化为中石化股份的控股子公司，湖南石化为上海上市规则下本公司之关联方及香 港上市规则下本公司的关联（连）人士。因此，本公司与湖南石化的交易构成本公司的关联交易（即关 联（连）交易，下同）。 ● 本次交易未构成《上市公司重大资产重组管理办法》规定的重大资产重组。 ● 根据上海上市规则，本次关联交易及本公司与同一关联人于本公告刊发之日前12个月内发生的关联交 易（已根据上海上市规则的规定审议披露的除外）的累计金额将高于本公司2024年度经审计净资产的 5%，本次关联交易需提交本公司股东会批准。根据香港上市规则，由于本次并表所适用的百分比率超 过5%，本次并表须遵守香港上市规则第十四A章项下申报、公告及独立股东批准的规定。由于本次并 表所适用的百分比率超过5%但低于25%，故根据香港上市规则第十四章，本次并表构成本公司的须予 披露交易，并须遵守香港上市规则第十四章项下申报及公告的规定。 证券代码：600688 股票简称：上海石化 编号：临2026-002 中国石化上海石油化工股份有限公司 关于并表合资 ...

格隆汇1月8日丨上海石化(600688.SH)公布，第十一届董事会第二十四次会议于2026年1月8日召开，审 议并批准关于本公司并表上海金山巴陵新材料有限公司（简称"巴陵新材料"）的议案，同意修订巴陵新 材料章程和合资合同条款，将巴陵新材料纳入本公司的合并报表范围。本次关联交易尚需经本公司股东 会审议通过。本公司于临时股东会审议批准本次并表后将不晚于2026年3月31日与湖南石化签订新合资 合同。 中石化股份持有本公司已发行股本约51.81%，为本公司的控股股东，中石化股份持有湖南石化74.69% 股权，湖南石化为中石化股份的控股子公司，湖南石化为上海上市规则下本公司之关联方及香港上市规 则下本公司的关联（连）人士。因此，本公司与湖南石化的交易构成本公司的关联交易（即关联（连） 交易，下同）。 ...

Core Viewpoint - The company announced that its first extraordinary general meeting of shareholders for 2026 will be held on January 8, 2026, combining on-site and online voting methods [1] Group 1: Meeting Details - The meeting is convened by the board of directors and will include 67 shareholders and authorized agents participating in the voting, representing 223,582,289 shares with voting rights, which accounts for 53.3370% of the total voting shares [1] - The meeting reviewed and approved the proposal regarding share repurchase through centralized bidding, which was passed as a special resolution, and the proposal for the estimated daily related party transaction limit for 2026, which was passed as an ordinary resolution, with related shareholders abstaining from voting [1] - Legal counsel confirmed that all procedures and voting results of the meeting are lawful and valid [1]

Core Viewpoint - Jiangsu Jicui Yaokang Biotechnology Co., Ltd. (referred to as "Yaokang Bio") is partially exiting its investment in Jiangxi Zhonghong Boyuan Biotechnology Co., Ltd. through a directed capital reduction, returning an investment of RMB 10 million and receiving a corresponding compensation for fund occupation at an annual interest rate of 5% [2][3]. Summary by Sections 1. Overview of Related Transactions - As of the announcement date, Yaokang Bio has invested RMB 70 million in Jiangxi Zhonghong, holding 22.8261% of its shares. The company will reduce its investment through a directed capital reduction, receiving RMB 10 million back and adjusting its shareholding to 20.2247% [4][10]. - If Jiangxi Zhonghong agrees to allow other shareholders to also reduce their investments by a total of RMB 15 million, Yaokang Bio's shareholding will adjust to 20.9302% [4][10]. 2. Related Party Information - Jiangxi Zhonghong is classified as a related party due to Yaokang Bio's shareholding [6]. 3. Transaction Pricing - The historical total investment by Yaokang Bio is RMB 70 million, and the capital reduction of RMB 10 million corresponds to a shareholding reduction of 2.6014% [10]. - The compensation for fund occupation is calculated to be RMB 1,657,534.25, based on the formula provided [10][12]. 4. Necessity and Impact of the Transaction - The transaction aligns with the overall development strategy and operational plans of the company, and it is not expected to negatively impact the financial status or operational results of Yaokang Bio [21]. 5. Review Procedures - The independent directors and the audit committee have approved the transaction, confirming that the pricing is fair and does not harm the interests of other shareholders [22][23][24].

Core Viewpoint - The announcement from Wanxin Media indicates a strategic asset operation model involving the repurchase of assets and rights, with a focus on a specific redemption date for a financial plan [1] Group 1: Asset Operation and Transactions - Wanxin Media will repurchase the assets and rights before transferring them as part of an innovative asset operation model [1] - The third redemption exercise date for the CITIC Wanxin Yuejia special plan is set for January 19, 2026 [1] - The transaction involves eight project companies and five subsidiary companies, with related party transactions occurring during the transition period [1] Group 2: Financial Obligations - The total rental payment obligation for the subsidiary companies until the irrevocable remaining lease term, which ends on September 30, 2036, is approximately 153 million yuan [1] - The transaction has been approved through relevant meetings and does not require shareholder meeting approval [1]

药康生物公告称，公司前期向江西中洪投资7000万元，现双方协商，公司拟通过定向减资方式部分退出 投资。江西中洪同意返还1000万元减资额，并支付对应资金占用补偿（年利率5%）。公司持股比例将 从22.8261%降至20.2247%；若苏州济康和苏州国发同步退出1500万元，公司持股比例降至20.9302%。 本次交易构成关联交易，不构成重大资产重组，尚需各方完成审议程序。过去12个月内，双方累计关联 交易168.11万元。 ...

Core Viewpoint - Guanshang Technology (301213.SZ) resumed trading today with a price increase of 20.00%, reaching 82.86 yuan, resulting in a total market capitalization of 6.629 billion yuan. The company disclosed a plan to acquire 100% of Liaojing Electronics through a combination of issuing shares and cash payment, which will make Liaojing a wholly-owned subsidiary of Guanshang Technology [1]. Group 1: Acquisition Details - The acquisition involves purchasing 100% of Liaojing Electronics from its controlling shareholder, Su Zhou, who is expected to repurchase 3.6311% of the company's shares from existing shareholders before the transaction is finalized [1]. - The specific number of shares to be issued and the cash payment amount will be determined based on the final transaction price, which will be disclosed in the restructuring report [2]. - The issuance price for the shares is set at 48.06 yuan per share, with the company planning to raise funds from no more than 35 specific investors, with the total amount not exceeding 100% of the transaction price [3]. Group 2: Financial Performance of Liaojing Electronics - Liaojing Electronics reported revenues of 147.24 million yuan, 114.18 million yuan, and 131.51 million yuan for the years 2023, 2024, and the first nine months of 2025, respectively. The net profits for the same periods were 54.91 million yuan, 25.51 million yuan, and 40.57 million yuan [5]. - As of September 30, 2025, Liaojing's total assets were 593.27 million yuan, with total liabilities of 117.79 million yuan and equity of 475.48 million yuan [6]. Group 3: Implications of the Transaction - The transaction is expected to constitute a related party transaction, as Su Zhou and his associates may hold more than 5% of the company's shares post-transaction, thus becoming related parties under the Shenzhen Stock Exchange rules [4]. - This acquisition is classified as a significant asset restructuring but does not constitute a reverse listing. Liaojing Electronics is a key supplier in the defense technology sector, specializing in semiconductor discrete devices and integrated circuits, with applications in aerospace, military, and nuclear physics [5].